The following studies, however, support an association between ADAM17 expression and gastric cancer prognosis.Shou et al. reported that patients with gastric cancer with high ADAM17 expression had a longer mean survival time than patients with low expression (P < 0.05), particularly those with stage II gastric cancer (P < 0.01) [98]. This evidence concerns the gene ADAM17 and gastric cancer.